Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of drugs targeting neurological disorders. Its boronic acid group enables it to participate in Suzuki-Miyaura cross-coupling reactions, facilitating the creation of complex organic molecules. The deuterium-labeled propyl group enhances metabolic stability, making it valuable in drug discovery and development studies. It is also employed in the production of agrochemicals, aiding in the creation of compounds with improved efficacy and environmental safety. Additionally, its trifluoromethyl group contributes to the lipophilicity and bioavailability of the final products, making it a versatile building block in medicinal chemistry.